Intensive Care Med (2021) 47:790–791 https://doi.org/10.1007/s00134-021-06425-y IMAGING IN INTENSIVE CARE MEDICINE Fatal cerebral venous sinus thrombosis after COVID‑19 vaccination Matthieu Jamme1,2* , Elie Mosnino1, Jan Hayon1 and Guillaume Franchineau1,3 © 2021 Springer-Verlag GmbH Germany, part of Springer Nature A 69-year-old woman with arterial hypertension treated daily by hydrochlorothiazide and angiotensin receptor antagonist received a first dose of Oxford–AstraZeneca vaccine. Eleven days after the vaccination, the patient developed headache associated with behavioral symptoms. At day 13, her daughter found her unconscious. Physical exami- nation revealed a coma Glasgow 4/15, right mydriasis, Fig. 1 Cerebral venous thrombosis with bilateral frontal intraparenchymatous hemorrhage. A T2 FLAIR sequencing revealed bilateral left (80 blood flow in sigmoids and superior sagittal sinus 23 mm) intra parenchymatous frontal hemorraghe. B Venous phase contrast MRI study showed an absence of venous 53 mm) and right (56 × × *Correspondence: matthieu.jamme@ght-yvelinesnord.fr 1 Service de Réanimation polyvalente, Centre hospitalier intercommunal de Poissy Saint Germain en Laye (CHIPS), 10 rue du champ Gaillard, 78300 Poissy, France Full author information is available at the end of the article 791 bilateral Babinski reflex without hemodynamic instability or respiratory failure. She was intubated and transferred in our intensive care unit. Immediate CT scan followed by MRI highlighted a severe bilateral frontal hemorrhage with brain hernia- tion complicating a cerebral venous thrombosis of the left internal jugular vein, sigmoid sinus and superior sag- ittal sinus (Fig.  1). Moreover, thoracic CT scan showed concomitant segmentary pulmonary embolism. Blood analysis at admission revealed an isolated thrombopenia measured at 18G/L with positive anti-PF4 antibodies. Evolution was dramatically poor in the next few hours with brain death, leading to an organ donation procedure. Author details 1 Service de Réanimation polyvalente, Centre hospitalier intercommunal de Poissy Saint Germain en Laye (CHIPS), 10 rue du champ Gaillard, 78300 Poissy, France. 2 INSERM U1018, Centre de recherche en épidémiologie et santé des populations (CESP), Equipe “Rein et Cœur”, Université Paris Saclay, 16 avenue Paul Vaillant Couturier, 94800 Villejuif, France. 3 INSERMUMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Sorbonne Universités, UPMC Univ Paris 06, 75651 Paris Cedex 13, France. Author contributions MJ, EM, JH and GF wrote the manuscript. Declarations Conflicts of interest The authors have no conflict of interest to declare. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in pub- lished maps and institutional affiliations. Received: 22 April 2021 Accepted: 27 April 2021 Published online: 13 May 2021